RALLYBIO CORPORATION Restructuring Reserve
RALLYBIO CORPORATION (RLYB) had Restructuring Reserve of $858.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2026-08-06
- 2026-06-30: Restructuring Reserve $858.00K.
- 2026-03-31: Restructuring Reserve $1.38M.
- 2025-12-31: Restructuring Reserve $523.00K.
| Period end | Restructuring Reserve |
|---|---|
| 2026-06-30 | $858.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.38M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $523.00K 10-Q · filed 2026-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |